270 studies found for:    "Expanded Access" [STUDY-TYPES]
Show Display Options
Rank Status Study
21 Unknown  Second Line Therapy to Treat Age-Related Macular Degeneration (AMD) for Patients Not Responding Well to Lucentis Therapy by Itself
Condition: Age Related Macular Degeneration
Interventions: Drug: Visudyne;   Drug: Lucentis;   Drug: Dexamethasone
22 Available A Humanitarian Device Exemption Treatment Protocol of TheraSphere For Treatment of Unresectable Hepatocellular Carcinoma
Condition: Liver Cancer
Intervention: Device: Theraspheres
23 Available Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell Transplant
Conditions: Acute Lymphoblastic Leukemia;   Acute Myeloid Leukemia;   Chronic Myeloid Leukemia;   Myelodysplastic Syndrome;   Lymphomas;   Bone Marrow Failure;   Hemoglobinopathy;   Immune Deficiency;   Osteopetrosis;   Cytopenias;   White Blood Cell Abnormalities;   Red Blood Cell Abnormalities
Intervention: Biological: CD34+ enriched, T Cell Depleted donor stem cell product
24 Available Compassionate Use of Dolutegravir and Ibalizumab for the Treatment of HIV Infection
Condition: Human Immunodeficiency Virus (HIV)
Interventions: Drug: Dolutegravir;   Drug: Ibalizumab
25 Available Allogeneic Virus-Specific Cytotoxic T-Lymphocytes(CTL), Persistent/Recurrent Viral Infection Post-HSCT (EAP CHALLAH)
Conditions: EBV Infection;   CMV Infection;   Adenoviral Infection
Intervention: Biological: Trivirus-Specific CTLs
26 Approved for marketing Expanded Access Use of Myozyme (Alglucosidase Alfa) in Patients With Infantile-onset Pompe Disease
Conditions: Glycogen Storage Disease Type II;   Glycogenosis 2
Intervention: Biological: alglucosidase alfa
27 Unknown  Efficacy and Safety Study of Neoadjuvant Chemotherapy for Local Advanced Triple Negative Breast Cancer Patients
Condition: Triple Negative Local Advanced Breast Cancer
Intervention: Drug: docetaxel oxaliplatin
28 Approved for marketing Korean Early Access Program
Condition: Leukemia
Intervention: Drug: Dasatinib
29 Available Expanded Treatment Prot of Panobinostat in Combo w/ Bortez and Dex in Pts w/ Relapsed and/or Refractory Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: Panobinostat
30 Approved for marketing Comparison of Biodegradable and Titanium Fixation Systems in Mandibular Symphysis or Parasymphysis Solitary Fractures
Conditions: Mandible Fracture;   Rigid Internal Fixation;   Three-dimensional Finite Element
Intervention: Other: Biodegradable and titanium fixation used in mandibular fractures.
31 Available Expanded Access Study Of Palbociclib (PD-0332991) In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR-Positive, Her2-Negative Advanced Breast Cancer For Whom Letrozole Therapy Is Deemed Appropriate
Condition: Advanced Breast Cancer (Female)
Interventions: Drug: Palbociclib;   Drug: Letrozole
32 No longer available Therasphere® for Treatment of Unresectable Primary Liver Cancer and Metastatic Liver Cancer
Conditions: Carcinoma, Hepatocellular;   Neoplasm Metastasis
Intervention: Device: yttrium Y 90 microspheres (Therasphere®)
33 No longer available Emergency/Compassionate Use - AMPLATZER Duct Occluder
Conditions: Patent;   Ductus;   Arteriosus
Intervention: Device: Device closure with the AMPLATZER Duct Occluder
34 No longer available Local Open-Label Access Study For Patients Who Completed A1481244 Study In Brazil
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: sildenafil (Revatio) 20 mg TID
35 Approved for marketing Access Program With Denileukin Diftitox for the Treatment of Patients Currently Receiving Treatment With Commercially Available (Ontak)
Condition: Cancer
Intervention: Drug: Denileukin diftitox (ONTAK)
36 Available 131-I-MIBG Therapy for Refractory Neuroblastoma and Metastatic Pheochromocytoma
Conditions: Neuroblastoma;   Childhood Metastatic Pheochromocytoma
Interventions: Drug: 131 I-Metaiodobenzylguanidine (131 I-MIBG);   Drug: 131 I-MIBG
37 Available Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis (EAP)
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: nintedanib
38 Temporarily not available The Change of Pulmonary Blood Flow During One Lung Ventilation
Condition: One Lung Ventilation
Intervention: Procedure: one lung ventilation
39 No longer available Real World Expanded Multi-center Study of the MitraClip System (REALISM)
Conditions: Mitral Valve Insufficiency;   Mitral Valve Regurgitation;   Mitral Valve Incompetence;   Mitral Regurgitation;   Mitral Insufficiency
Intervention: Device: MitraClip
40 Available Tecovirimat (ST-246) Treatment for Orthopox Virus Exposure
Conditions: Smallpox;   Monkeypox
Intervention: Drug: Tecovirimat

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years